RÉSUMÉ
HHLA2, a member of the B7 family of co-signaling molecules, is aberrantly expressed in various human cancers and has emerged as a promising target for cancer immunotherapy. It exhibits a unique structure and tissue distribution pattern compared to other B7 family members, where its expression is regulated by the complex physiological and tumor microenvironment. HHLA2 plays a crucial but contradictory role in immune modulation, and is thereby associated with heterogeneous prognostic implications across different cancer types. It interacts with two distinct receptors: TMIGD2, which is predominantly expressed on naïve T and NK cells to deliver co-stimulatory signals to T cells and NK cells; and KIR3DL3, which is prevalent on terminally differentiated T and CD56dim CD16+ NK cells to transmit inhibitory signals. The expression dynamics of these receptors on immune cells contribute to the maintenance of immune response homeostasis. Therapeutic strategies targeting the HHLA2 immune checkpoint aim to selectively inhibit the immunosuppressive HHLA2-KIR3DL3 pathway while preserving the HHLA2-TMIGD2 signaling. Several anti-HHLA2 and anti-KIR3DL3 antibodies are currently under investigation in early clinical trials, building upon encouraging results observed in humanized mouse models. Notably, the non-overlapping expression of HHLA2 and PD-L1 in tumors suggests potential synergistic benefits of combining HHLA2-KIR3DL3 targeted therapies with PD-1/PD-L1 blockade or anti-CTLA-4 to augment antitumor activity.
RÉSUMÉ
Macrophages play a pivotal role in orchestrating the immune response against pathogens. While the intricate interplay between macrophage activation and metabolism remains a subject of intense investigation, the role of glutamate oxaloacetate transaminase 1 (Got1) in this context has not been extensively assessed. Here, we investigate the impact of Got1 on macrophage polarization and function, shedding light on its role in reactive oxygen species (ROS) production, pathogen defense, and immune paralysis. Using genetically modified mouse models, including both myeloid specific knockout and overexpression, we comprehensively demonstrate that Got1 depletion leads to reduced ROS production in macrophages. Intriguingly, this impairment in ROS generation does not affect the resistance of Got1 KO mice to pathogenic challenges. Furthermore, Got1 is dispensable for M2 macrophage differentiation and does not influence the onset of LPS-induced immune paralysis. Our findings underscore the intricate facets of macrophage responses, suggesting that Got1 is dispensable in discrete immunological processes.
Sujet(s)
Différenciation cellulaire , Macrophages , Souris knockout , Espèces réactives de l'oxygène , Animaux , Souris , Aspartate aminotransferase, cytoplasmic/génétique , Aspartate aminotransferase, cytoplasmic/métabolisme , Lipopolysaccharides/pharmacologie , Activation des macrophages/génétique , Macrophages/immunologie , Macrophages/métabolisme , Souris de lignée C57BL , Espèces réactives de l'oxygène/métabolismeRÉSUMÉ
The tumor microenvironment (TME) has a significant impact on tumor growth and immunotherapy efficacies. However, the precise cellular interactions and spatial organizations within the TME that drive these effects remain elusive. Using advanced multiplex imaging techniques, we have discovered that regulatory T cells (Tregs) accumulate around lymphatic vessels in the peripheral tumor stroma. This localized accumulation is facilitated by mature dendritic cells enriched in immunoregulatory molecules (mregDCs), which promote chemotaxis of Tregs, establishing a peri-lymphatic Treg-mregDC niche. Within this niche, mregDCs facilitate Treg activation, which in turn restrains the trafficking of tumor antigens to the draining mesenteric lymph nodes, thereby impeding the initiation of anti-tumor adaptive immune responses. Disrupting Treg recruitment to mregDCs inhibits tumor progression. Our study provides valuable insights into the organization of TME and how local crosstalk between lymphoid and myeloid cells suppresses anti-tumor immune responses.
Sujet(s)
Cellules dendritiques , Lymphocytes T régulateurs , Microenvironnement tumoral , Lymphocytes T régulateurs/immunologie , Animaux , Microenvironnement tumoral/immunologie , Souris , Cellules dendritiques/immunologie , Cellules dendritiques/métabolisme , Humains , Antigènes néoplasiques/immunologie , Antigènes néoplasiques/métabolisme , Vaisseaux lymphatiques/immunologie , Vaisseaux lymphatiques/métabolisme , Souris de lignée C57BL , Noeuds lymphatiques/immunologie , Lignée cellulaire tumorale , Tumeurs/immunologie , Tumeurs/métabolismeRÉSUMÉ
Rosamine-based mitochondrial dyes, such as Mitotracker Red, have commonly been employed to visualize mitochondrial localization within cells due to their preferential accumulation in organelles with membrane potential. Consequently, Mitotracker Red has often served as a surrogate indicator for tracking mitochondrial movement between neighboring cells. However, it is important to note that the presence of membrane potential in the cell membrane and other organelles may lead to the non-specific partial enrichment of Mitotracker Red in locations other than mitochondria. This study comprehensively investigates the reliability of mitochondrial dye as a marker for studying horizontal mitochondrial transfer (HMT). By meticulous replicating of previous experiments and comparing the efficiency of mitochondrial dye transfer with that of mito-targeted GFP, our findings confirm that HMT occurs at significantly lower efficiency than previously indicated by Mitotracker dye. Subsequent experiments involving mitochondria-deficient cells robustly demonstrates the non-specificity of mitochondrial dye as indicator for mitochondria. We advocate for a thorough reevaluation of existing literature in this field and propose exploration of alternative techniques to enhance the investigation of HMT. By addressing these pivotal aspects, we can advance our understanding of cellular dynamics and pave the way for future explorations in this captivating field.
Sujet(s)
Agents colorants , Mitochondries , Reproductibilité des résultats , Membrane cellulaire , Potentiels de membraneRÉSUMÉ
Type 1 conventional dendritic cells (cDC1) are the most efficient cross-presenting cells that induce protective cytotoxic T cell response. However, the regulation of their homeostasis and function is incompletely understood. Here we observe a selective reduction of splenic cDC1 accompanied by excessive cell death in mice with Zeb1 deficiency in dendritic cells, rendering the mice more resistant to Listeria infection. Additionally, cDC1 from other sources of Zeb1-deficient mice display impaired cross-presentation of exogenous antigens, compromising antitumor CD8+ T cell responses. Mechanistically, Zeb1 represses the expression of microRNA-96/182 that target Cybb mRNA of NADPH oxidase Nox2, and consequently facilitates reactive-oxygen-species-dependent rupture of phagosomal membrane to allow antigen export to the cytosol. Cybb re-expression in Zeb1-deficient cDC1 fully restores the defective cross-presentation while microRNA-96/182 overexpression in Zeb1-sufficient cDC1 inhibits cross-presentation. Therefore, our results identify a Zeb1-microRNA-96/182-Cybb pathway that controls cross-presentation in cDC1 and uncover an essential role of Zeb1 in cDC1 homeostasis.
Sujet(s)
microARN , Facteurs de transcription , Animaux , Souris , Antigènes/métabolisme , Lymphocytes T CD8+ , Cellules dendritiques , Homéostasie , microARN/génétique , microARN/métabolisme , Facteurs de transcription/métabolismeRÉSUMÉ
The emergence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) variants and "anatomical escape" characteristics threaten the effectiveness of current coronavirus disease 2019 (COVID-19) vaccines. There is an urgent need to understand the immunological mechanism of broad-spectrum respiratory tract protection to guide broader vaccines development. Here we investigate immune responses induced by an NS1-deleted influenza virus vectored intranasal COVID-19 vaccine (dNS1-RBD) which provides broad-spectrum protection against SARS-CoV-2 variants in hamsters. Intranasal delivery of dNS1-RBD induces innate immunity, trained immunity and tissue-resident memory T cells covering the upper and lower respiratory tract. It restrains the inflammatory response by suppressing early phase viral load post SARS-CoV-2 challenge and attenuating pro-inflammatory cytokine (Il6, Il1b, and Ifng) levels, thereby reducing excess immune-induced tissue injury compared with the control group. By inducing local cellular immunity and trained immunity, intranasal delivery of NS1-deleted influenza virus vectored vaccine represents a broad-spectrum COVID-19 vaccine strategy to reduce disease burden.
Sujet(s)
COVID-19 , Vaccins antigrippaux , Grippe humaine , Animaux , Cricetinae , Humains , Vaccins contre la COVID-19 , SARS-CoV-2 , COVID-19/prévention et contrôleRÉSUMÉ
T helper type 2 (Th2) cytokine-activated M2 macrophages contribute to inflammation resolution and wound healing. This study shows that IL-4-primed macrophages exhibit a stronger response to lipopolysaccharide stimulation while maintaining M2 signature gene expression. Metabolic divergence between canonical M2 and non-canonical proinflammatory-prone M2 (M2INF) macrophages occurs after the IL-4Rα/Stat6 axis. Glycolysis supports Hif-1α stabilization and proinflammatory phenotype of M2INF macrophages. Inhibiting glycolysis blunts Hif-1α accumulation and M2INF phenotype. Wdr5-dependent H3K4me3 mediates the long-lasting effect of IL-4, with Wdr5 knockdown inhibiting M2INF macrophages. Our results also show that the induction of M2INF macrophages by IL-4 intraperitoneal injection and transferring of M2INF macrophages confer a survival advantage against bacterial infection in vivo. In conclusion, our findings highlight the previously neglected non-canonical role of M2INF macrophages and broaden our understanding of IL-4-mediated physiological changes. These results have immediate implications for how Th2-skewed infections could redirect disease progression in response to pathogen infection.
Sujet(s)
Interleukine-4 , Macrophages , Humains , Interleukine-4/pharmacologie , Interleukine-4/métabolisme , Macrophages/métabolisme , Inflammation/métabolisme , Cytokines/métabolisme , Glycolyse/physiologie , Sous-unité alpha du facteur-1 induit par l'hypoxie/métabolisme , Protéines et peptides de signalisation intracellulaire/métabolismeRÉSUMÉ
Small cell lung cancer (SCLC) continues to cause poor clinical outcomes due to limited advances in sustained treatments for rapid cancer cell proliferation and progression. The transcriptional factor Forkhead Box M1 (FOXM1) regulates cell proliferation, tumor initiation, and progression in multiple cancer types. However, its biological function and clinical significance in SCLC remain unestablished. Analysis of the Cancer Cell Line Encyclopedia and SCLC datasets in the present study disclosed significant upregulation of FOXM1 mRNA in SCLC cell lines and tissues. Gene set enrichment analysis (GSEA) revealed that FOXM1 is positively correlated with pathways regulating cell proliferation and DNA damage repair, as evident from sensitization of FOXM1-depleted SCLC cells to chemotherapy. Furthermore, Foxm1 knockout inhibited SCLC formation in the Rb1fl/flTrp53fl/flMycLSL/LSL (RPM) mouse model associated with increased levels of neuroendocrine markers, Ascl1 and Cgrp, and decrease in Yap1. Consistently, FOXM1 depletion in NCI-H1688 SCLC cells reduced migration and enhanced apoptosis and sensitivity to cisplatin and etoposide. SCLC with high FOXM1 expression (N = 30, 57.7%) was significantly correlated with advanced clinical stage, extrathoracic metastases, and decrease in overall survival (OS), compared with the low-FOXM1 group (7.90 vs. 12.46 months). Moreover, the high-FOXM1 group showed shorter progression-free survival after standard chemotherapy, compared with the low-FOXM1 group (3.90 vs. 8.69 months). Our collective findings support the utility of FOXM1 as a prognostic biomarker and potential molecular target for SCLC.
Sujet(s)
Marqueurs biologiques tumoraux , Protéine M1 à motif en tête de fourche/génétique , Tumeurs du poumon/étiologie , Tumeurs du poumon/mortalité , Carcinome pulmonaire à petites cellules/étiologie , Carcinome pulmonaire à petites cellules/mortalité , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Animaux , Lignée cellulaire tumorale , Prolifération cellulaire , Modèles animaux de maladie humaine , Femelle , Protéine M1 à motif en tête de fourche/métabolisme , Analyse de profil d'expression de gènes , Régulation de l'expression des gènes tumoraux , Humains , Immunohistochimie , Estimation de Kaplan-Meier , Tumeurs du poumon/diagnostic , Mâle , Souris , Souris transgéniques , Adulte d'âge moyen , Grading des tumeurs , Stadification tumorale , Pronostic , Carcinome pulmonaire à petites cellules/diagnostic , Microtomographie aux rayons X , Tests d'activité antitumorale sur modèle de xénogreffeRÉSUMÉ
Sleep apnea has been associated with a variety of diseases, but its impact on sepsis outcome remains unclear. This study investigated the effect of intermittent hypoxia [IH]-the principal feature of sleep apnea-on murine sepsis. 5-week-old male C57BL6 mice were assigned to groups receiving severe IH (O2 fluctuating from room air to an O2 nadir of 5.7% with a cycle length of 90 seconds), mild IH (room air to 12%, 4 minutes/cycle), or room air for 3 weeks. Sepsis was induced by cecal ligation and puncture and survival was monitored. Sepsis severity was evaluated by murine sepsis scores, blood bacterial load, plasma tumor necrosis factor-α [TNF-α]/interleukin-6 [IL-6] levels and histopathology of vital organs. Compared with normoxic controls, mice subjected to severe IH had earlier mortality, a lower leukocyte count, higher blood bacterial load, higher plasma TNF-α and IL-6 levels, more severe inflammatory changes in the lung, spleen and small intestine. Mice subjected to mild IH did not differ from normoxic controls, except a higher IL-6 level after sepsis induced. The adverse impact of severe IH was reversed following a 10-day normoxic recovery. In conclusion, severe IH, not mild IH, contributed to poorer outcomes in a murine sepsis model.
Sujet(s)
Hypoxie/métabolisme , Sepsie/métabolisme , Sepsie/mortalité , Animaux , Marqueurs biologiques , Biopsie , Modèles animaux de maladie humaine , Médiateurs de l'inflammation , Mâle , Souris , Pronostic , Sepsie/diagnostic , Sepsie/étiologieRÉSUMÉ
High-mobility group nucleosome-binding protein 1 (HMGN1) functions as a non-histone chromatin-binding protein in the cell nucleus. However, extracellular HMGN1 acts as an endogenous danger-associated inflammatory mediator (also called alarmin). We demonstrated that HMGN1 not only directly stimulated cytokine production but also had the capacity to induce immune tolerance by a TLR4-dependent pathway, similar to lipopolysaccharide (LPS)-induced tolerance. HMGN1-induced tolerance was accompanied by a metabolic shift associated with the inhibition of the induction of Warburg effect (aerobic glycolysis) and histone deacetylation via Sirtuin-1. In addition, HMGN1 pre-challenge of mice also downregulated TNF production similar to LPS-induced tolerance in vivo. In conclusion, HMGN1 is an endogenous TLR4 ligand that can induce both acute stimulation of cytokine production and long-term tolerance, and thus it might play a modulatory role in sterile inflammatory processes such as those induced by infection, trauma, or ischemia.
Sujet(s)
Protéine HMGN1/immunologie , Agranulocytes/immunologie , Sirtuine-1/immunologie , Récepteur de type Toll-4/immunologie , Animaux , Cytokines/sang , Femelle , Humains , Tolérance immunitaire , Immunité innée , Ligands , Souris de lignée C57BLRÉSUMÉ
Background and Aims: Crohn's disease [CD] is a chronic inflammatory disease with unpredictable behaviour. More than half of CD patients eventually develop complications such as stenosis, for which they then require endoscopic dilatation or surgery, as no anti-fibrotic drugs are currently available. We aim to identify disease-modifying genes associated with fibrostenotic CD. Methods: We performed a within-case analysis comparing 'extreme phenotypes' using the Immunochip and replication of the top single nucleotide polymorphisms [SNPs] with Agena Bioscience in two independent case-control cohorts totalling 322 cases with fibrostenotis [recurrent after surgery] and 619 cases with purely inflammatory CD. Results: Combined meta-analysis resulted in a genome-wide significant signal for SNP rs11861007 [p = 6.0910-11], located on chromosome 16, in lncRNA RP11-679B19.1, an lncRNA of unknown function, and close to exon 9 of the WWOX gene, which codes for WW domain-containing oxidoreductase. We analysed mRNA expression of TGF-ß and downstream genes in ileocecal resection material from ten patients with and without the WWOX risk allele. Patients carrying the risk allele [A] showed enhanced colonic expression of TGF-ß compared to patients homozygous for the wild-type [G] allele [p = 0.0079]. Conclusion: We have identified a variant in WWOX and in lncRNA RP11-679B19.1 as a disease-modifying genetic variant associated with recurrent fibrostenotic CD and replicated this association in an independent cohort. WWOX can potentially play a crucial role in fibrostenosis in CD, being positioned at the crossroads of inflammation and fibrosis.
Sujet(s)
Maladie de Crohn/génétique , Maladie de Crohn/métabolisme , ARN messager/métabolisme , Protéines suppresseurs de tumeurs/génétique , Oxydoréductase contenant des domaines WW/génétique , Adolescent , Adulte , Allèles , Études cas-témoins , Sténose pathologique/étiologie , Maladie de Crohn/complications , Femelle , Fibrose , Étude d'association pangénomique , Génomique , Humains , Mâle , Phénotype , Polymorphisme de nucléotide simple , ARN long non codant/génétique , Facteur de croissance transformant bêta/génétique , Jeune adulteRÉSUMÉ
Induction of trained immunity (innate immune memory) is mediated by activation of immune and metabolic pathways that result in epigenetic rewiring of cellular functional programs. Through network-level integration of transcriptomics and metabolomics data, we identify glycolysis, glutaminolysis, and the cholesterol synthesis pathway as indispensable for the induction of trained immunity by ß-glucan in monocytes. Accumulation of fumarate, due to glutamine replenishment of the TCA cycle, integrates immune and metabolic circuits to induce monocyte epigenetic reprogramming by inhibiting KDM5 histone demethylases. Furthermore, fumarate itself induced an epigenetic program similar to ß-glucan-induced trained immunity. In line with this, inhibition of glutaminolysis and cholesterol synthesis in mice reduced the induction of trained immunity by ß-glucan. Identification of the metabolic pathways leading to induction of trained immunity contributes to our understanding of innate immune memory and opens new therapeutic avenues.
Sujet(s)
Épigenèse génétique , Fumarates/métabolisme , Glutamine/métabolisme , Immunité innée/génétique , Cholestérol/métabolisme , Glucose/métabolisme , Glycolyse , Humains , Sous-unité alpha du facteur-1 induit par l'hypoxie/métabolisme , Tolérance immunitaire , Macrophages/métabolisme , Modèles biologiques , Voie des pentoses phosphates/génétique , ProtéolyseRÉSUMÉ
Cells in homeostasis metabolize glucose mainly through the tricarboxylic acid cycle and oxidative phosphorylation, while activated cells switch their basal metabolism to aerobic glycolysis. In this study, we examined whether metabolic reprogramming toward aerobic glycolysis is important for the host response to Mycobacterium tuberculosis (Mtb). Through transcriptional and metabolite analysis we show that Mtb induces a switch in host cellular metabolism toward aerobic glycolysis in human peripheral blood mononuclear cells (PBMCs). The metabolic switch is TLR2 dependent but NOD2 independent, and is mediated in part through activation of the AKT-mTOR (mammalian target of rapamycin) pathway. We show that pharmacological inhibition of the AKT/mTOR pathway inhibits cellular responses to Mtb both in vitro in human PBMCs, and in vivo in a model of murine tuberculosis. Our findings reveal a novel regulatory layer of host responses to Mtb that will aid understanding of host susceptibility to Mtb, and which may be exploited for host-directed therapy.
Sujet(s)
Glycolyse , Agranulocytes/métabolisme , Mycobacterium tuberculosis/immunologie , Protéines proto-oncogènes c-akt/métabolisme , Sérine-thréonine kinases TOR/métabolisme , Animaux , Antibactériens/pharmacologie , Analyse de profil d'expression de gènes , Glucose/métabolisme , Glycolyse/génétique , Interactions hôte-pathogène , Humains , Agranulocytes/immunologie , Agranulocytes/microbiologie , Souris , Phosphorylation oxydative , Transduction du signal/effets des médicaments et des substances chimiques , Sirolimus/pharmacologie , Sérine-thréonine kinases TOR/génétique , Sérine-thréonine kinases TOR/immunologie , Récepteur de type Toll-2/immunologie , Tuberculose/immunologie , Tuberculose/métabolisme , Tuberculose/microbiologieRÉSUMÉ
The acute phase of sepsis is characterized by a strong inflammatory reaction. At later stages in some patients, immunoparalysis may be encountered, which is associated with a poor outcome. By transcriptional and metabolic profiling of human patients with sepsis, we found that a shift from oxidative phosphorylation to aerobic glycolysis was an important component of initial activation of host defense. Blocking metabolic pathways with metformin diminished cytokine production and increased mortality in systemic fungal infection in mice. In contrast, in leukocytes rendered tolerant by exposure to lipopolysaccharide or after isolation from patients with sepsis and immunoparalysis, a generalized metabolic defect at the level of both glycolysis and oxidative metabolism was apparent, which was restored after recovery of the patients. Finally, the immunometabolic defects in humans were partially restored by therapy with recombinant interferon-γ, which suggested that metabolic processes might represent a therapeutic target in sepsis.
Sujet(s)
Cytokines/immunologie , Endotoxémie/immunologie , Métabolisme énergétique/immunologie , Tolérance immunitaire/immunologie , Immunité innée/immunologie , Macrophages/immunologie , Monocytes/immunologie , Sepsie/immunologie , Adénosine triphosphate/métabolisme , Adulte , Animaux , Antifongiques/usage thérapeutique , Aspergillose/traitement médicamenteux , Aspergillose/immunologie , Aspergillose/métabolisme , Candidose invasive/traitement médicamenteux , Candidose invasive/immunologie , Candidose invasive/métabolisme , Endotoxémie/métabolisme , Infections à Escherichia coli/immunologie , Infections à Escherichia coli/métabolisme , Femelle , Glycolyse , Humains , Immunotransfert , Interféron gamma/usage thérapeutique , Acide lactique/métabolisme , Leucocytes/immunologie , Leucocytes/métabolisme , Lipopolysaccharides/immunologie , Macrophages/métabolisme , Mâle , Souris , Adulte d'âge moyen , Monocytes/métabolisme , NAD/métabolisme , Phosphorylation oxydative , Consommation d'oxygène , Études prospectives , Sepsie/traitement médicamenteux , Sepsie/métabolisme , Transcriptome , Jeune adulteRÉSUMÉ
The immune system is essential to maintain the mutualistic homeostatic interaction between the host and its micro- and mycobiota. Living as a commensal,Saccharomyces cerevisiaecould potentially shape the immune response in a significant way. We observed thatS. cerevisiaecells induce trained immunity in monocytes in a strain-dependent manner through enhanced TNFα and IL-6 production upon secondary stimulation with TLR ligands, as well as bacterial and fungal commensals. Differential chitin content accounts for the differences in training properties observed among strains, driving induction of trained immunity by increasing cytokine production and direct antimicrobial activity bothin vitroandin vivo These chitin-induced protective properties are intimately associated with its internalization, identifying a critical role of phagosome acidification to facilitate microbial digestion. This study reveals how commensal and passenger microorganisms could be important in promoting health and preventing mucosal diseases by modulating host defense toward pathogens and thus influencing the host microbiota-immune system interactions.
Sujet(s)
Chitine/immunologie , Immunité innée , Monocytes/microbiologie , Saccharomyces cerevisiae/immunologie , Animaux , Paroi cellulaire/immunologie , Humains , Interleukine-6/immunologie , Souris de lignée C57BL , Monocytes/immunologie , Phagocytose , Facteur de nécrose tumorale alpha/immunologieRÉSUMÉ
CARD9 is a central component of anti-fungal innate immune signaling via C-type lectin receptors, and several immune-related disorders are associated with CARD9 alterations. Here, we used a rare CARD9 variant that confers protection against inflammatory bowel disease as an entry point to investigating CARD9 regulation. We showed that the protective variant of CARD9, which is C-terminally truncated, acted in a dominant-negative manner for CARD9-mediated cytokine production, indicating an important role for the C terminus in CARD9 signaling. We identified TRIM62 as a CARD9 binding partner and showed that TRIM62 facilitated K27-linked poly-ubiquitination of CARD9. We identified K125 as the ubiquitinated residue on CARD9 and demonstrated that this ubiquitination was essential for CARD9 activity. Furthermore, we showed that similar to Card9-deficient mice, Trim62-deficient mice had increased susceptibility to fungal infection. In this study, we utilized a rare protective allele to uncover a TRIM62-mediated mechanism for regulation of CARD9 activation.
Sujet(s)
Protéines adaptatrices de signalisation CARD/physiologie , Candidose invasive/immunologie , Récepteurs aux angiotensines/physiologie , Récepteur endothéline/physiologie , Ubiquitin-protein ligases/physiologie , Adjuvants immunologiques/pharmacologie , Animaux , Protéines adaptatrices de signalisation CARD/composition chimique , Protéines adaptatrices de signalisation CARD/déficit , Protéines adaptatrices de signalisation CARD/génétique , Candidose invasive/génétique , Colite/induit chimiquement , Colite/génétique , Colite/prévention et contrôle , Cytokines/biosynthèse , Cellules dendritiques/immunologie , Cellules dendritiques/métabolisme , Gènes dominants , Prédisposition génétique à une maladie , Cellules HEK293 , Cellules HeLa , Humains , Maladies inflammatoires intestinales/génétique , Souris , Souris de souche-129 , Souris knockout , Cartographie d'interactions entre protéines , Isoformes de protéines/composition chimique , Isoformes de protéines/génétique , Isoformes de protéines/physiologie , Maturation post-traductionnelle des protéines , Structure tertiaire des protéines , Récepteurs aux angiotensines/composition chimique , Récepteurs aux angiotensines/déficit , Récepteur endothéline/composition chimique , Récepteur endothéline/déficit , Protéines de fusion recombinantes/métabolisme , Transduction du signal , Organismes exempts d'organismes pathogènes spécifiques , Protéines à motif tripartite , Ubiquitin-protein ligases/composition chimique , UbiquitinationRÉSUMÉ
Although it is known that Borrelia species express sugar-like structures on their outer surface, not much is known about the role of these structures in immune recognition by host cells. Fungi, like Candida albicans, are mainly recognized by C-type lectin receptors, in specific Dectin-1 and Dectin-2. In this study we assessed the role of Dectin-1 and Dectin-2 in the recognition process of Borrelia spirochetes. Using specific inhibitors against these receptors on human cells did not influenced cytokine production. Individuals carrying a SNP leading to an early stop codon in the DECTIN-1 gene also did not lead to differential induction of Borrelia-dependent cytokines. After injection of live Borrelia into knee joints of Dectin-2 deficient mice a trend towards lower inflammation was observed. Inhibition of Syk in human cells resulted in lower cytokine production after Borrelia stimulation. In conclusion, Dectin-1 and Dectin-2 seem not to play a major role in Borrelia recognition or Borrelia-induced inflammation. However, Syk seems to be involved in Borrelia-induced cytokine production.
Sujet(s)
Borrelia burgdorferi/physiologie , Cytokines/biosynthèse , Protéines et peptides de signalisation intracellulaire/métabolisme , Lectines de type C/métabolisme , Protein-tyrosine kinases/métabolisme , Animaux , Femelle , Lectines de type C/génétique , Mâle , Souris , Souris de lignée C57BL , Souris knockout , Syk kinaseRÉSUMÉ
The induction of host defense against Candida species is initiated by recognition of the fungi by pattern recognition receptors and activation of downstream pathways that produce inflammatory mediators essential for infection clearance. In this study, we present complementary evidence based on transcriptome analysis, genetics, and immunological studies in knockout mice and humans that the cytosolic RIG-I-like receptor MDA5 (IFIH1) has an important role in the host defense against C. albicans. Firstly, IFIH1 expression in macrophages is specifically induced by invasive C. albicans hyphae, and patients suffering from chronic mucocutaneous candidiasis (CMC) express lower levels of MDA5 than healthy controls. Secondly, there is a strong association between missense variants in the IFIH1 gene (rs1990760 and rs3747517) and susceptibility to systemic Candida infections. Thirdly, cells from Mda5 knockout mice and human peripheral blood mononuclear cells (PBMCs) with different IFIH1 genotypes display an altered cytokine response to C. albicans. These data strongly suggest that MDA5 is involved in immune responses to Candida infection. As a receptor for viral RNA, MDA5 until now has been linked to antiviral host defense, but these novel studies show unexpected effects in antifungal immunity as well. Future studies are warranted to explore the potential of MDA5 as a novel target for immunotherapeutic strategies.
Sujet(s)
Candida/immunologie , Candidémie/immunologie , DEAD-box RNA helicases/métabolisme , Adulte , Animaux , Cellules cultivées , Études de cohortes , DEAD-box RNA helicases/déficit , Prédisposition aux maladies , Humains , Hélicase IFIH1 inductrice de l'interféron , Agranulocytes/immunologie , Agranulocytes/microbiologie , Souris knockout , Polymorphisme de nucléotide simpleRÉSUMÉ
BACKGROUND: Candida albicans is an opportunistic fungal pathogen that induces strong proinflammatory responses, such as IL-1ß production. Much less is known about the induction of immune modulatory cytokines, such as the IL-1 receptor antagonist (IL-1Ra) that is the main natural antagonist of IL-1, by C. albicans. METHODS: Peripheral blood mononuclear cells (PBMC) of healthy individuals were stimulated with C. albicans and different components of the fungal cell wall. The role of pathogen recognition receptors (PRRs) for the induction of IL-1ß and IL-1Ra was investigated by using specific blockers or in PBMC from Dectin-1 deficient patients. RESULTS: C. albicans induced a strong IL-1Ra response, and this induction was primarily induced by the cell-wall component ß-glucan. Blocking IL-1Ra significantly increased C. albicans ß-glucan hyphae induced IL-1ß and IL-6 production. Surprisingly, blocking the ß-glucan receptor Dectin-1 or the downstream Syk or Raf-1 pathways only marginally reduced C. albicans-induced IL-1Ra production, while blocking of the complement receptor 3 (CR3), TLR2 or TLR4 had no effect. In line with this, blocking MAP kinases had little effect on Candida-induced IL-1Ra production. PBMC isolated from Dectin-1 deficient patients produced normal IL-1Ra amounts in response to C. albicans stimulation. Interestingly, the IL-1Ra synthesis induced by ß-glucan was blocked by inhibitors of the Akt/PI3K pathway. CONCLUSIONS: ß-glucan of C. albicans induces a strong IL-1Ra response, which is independent of the ß-glucan receptors dectin-1 and CR3. These data strongly argue for the existence of an unknown ß-glucan receptor that specifically induces an Akt/PI3K-dependent anti-inflammatory IL-1Ra response upon recognition of C. albicans.